Systemic and inhaled fluoroquinolones: risk of heart valve regurgitation/incompetence
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
|
Active substance |
|
Regulatory outcome |
Variation
|
DHPC type |
Safety signal
|
Human ATC code |
|
Dissemination date |
29/10/2020
|
Related medicines |
|